Home > Qtrly Results > NATCO PHARMA

NATCO PHARMA
Quarterly Results Analysis [Jun2025]

NATCO PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for NATCO PHARMA
Please provide your vote to see the results

NATCO PHARMA Quarterly Results

Consolidated Jun2025
UnAudited
Mar2025
UnAudited
Dec2024
UnAudited
Sep2024
UnAudited
Jun2024
UnAudited
Mar2024
UnAudited
Dec2023
UnAudited
Sep2023
UnAudited
Revenues ₹1,329 Cr ₹1,221 Cr ₹475 Cr ₹1,371 Cr ₹1,363 Cr ₹1,068 Cr ₹759 Cr ₹1,031 Cr
Expenses ₹758 Cr ₹673 Cr ₹436 Cr ₹567 Cr ₹558 Cr ₹571 Cr ₹491 Cr ₹573 Cr
Operating Income ₹571 Cr ₹548 Cr ₹39 Cr ₹804 Cr ₹805 Cr ₹497 Cr ₹268 Cr ₹458 Cr
Other Income ₹62 Cr ₹66 Cr ₹176 Cr ₹64 Cr ₹48 Cr ₹42 Cr ₹37 Cr ₹29 Cr
Interest ₹3 Cr ₹10 Cr ₹4 Cr ₹4 Cr ₹5 Cr ₹6 Cr ₹5 Cr ₹4 Cr
Depreciation ₹58 Cr ₹98 Cr ₹47 Cr ₹46 Cr ₹44 Cr ₹56 Cr ₹44 Cr ₹44 Cr
Profit Before Tax ₹572 Cr ₹506 Cr ₹164 Cr ₹818 Cr ₹804 Cr ₹478 Cr ₹256 Cr ₹440 Cr
Profit After Tax ₹480 Cr ₹406 Cr ₹132 Cr ₹677 Cr ₹669 Cr ₹386 Cr ₹213 Cr ₹369 Cr
EPS ₹26.85 ₹22.72 ₹7.43 ₹37.84 ₹37.35 ₹21.58 ₹11.88 ₹20.61
Industry Peers & Returns1W1M1Y
NATCO PHARMA 0.9% -3.7% -43.6%
SUN PHARMACEUTICAL INDUSTRIES -0.3% 3.2% -13%
DIVIS LABORATORIES 7.2% 8.6% 6.8%
CIPLA 3% 0.7% -2.6%
TORRENT PHARMACEUTICALS -0.5% NA 0.6%
DR REDDYS LABORATORIES -1.1% -5.3% -6.3%
MANKIND PHARMA -1.4% -5.3% -12.8%
ZYDUS LIFESCIENCES -1.9% -5.7% -8.1%
LUPIN -0.9% -5.2% -12.9%

NATCO PHARMA Quarterly Revenues

Revenues
Q-o-Q

8.84 %

Y-o-Y

-2.47 %

Quarters Revenues % Change
Jun2025 ₹1,329 Cr
8.84
Mar2025 ₹1,221 Cr
157.16
Dec2024 ₹475 Cr
-65.37
Sep2024 ₹1,371 Cr
0.62
Jun2024 ₹1,363 Cr
27.55
Mar2024 ₹1,068 Cr
40.83
Dec2023 ₹759 Cr
-26.45
Sep2023 ₹1,031 Cr -

NATCO PHARMA Quarterly Operating Profit

Operating Profit
Q-o-Q

4.18 %

Y-o-Y

-29.05 %

Quarters Operating Profit % Change
Jun2025 ₹571 Cr
4.18
Mar2025 ₹548 Cr
1,312.63
Dec2024 ₹39 Cr
-95.18
Sep2024 ₹804 Cr
-0.06
Jun2024 ₹805 Cr
61.83
Mar2024 ₹497 Cr
85.49
Dec2023 ₹268 Cr
-41.46
Sep2023 ₹458 Cr -
Operating Margins
Q-o-Q

-4.28 %

Y-o-Y

-27.24 %

Quarters Operating Margin% % Change
Jun2025 42.97%
-4.28
Mar2025 44.89%
449.45
Dec2024 8.17%
-86.07
Sep2024 58.66%
-0.68
Jun2024 59.06%
26.87
Mar2024 46.55%
31.72
Dec2023 35.34%
-20.42
Sep2023 44.41% -

NATCO PHARMA Quarterly Profit After Tax

Profit After Tax(PAT)
Q-o-Q

18.30 %

Y-o-Y

-28.15 %

Quarters Profit After Tax % Change
Jun2025 ₹480 Cr
18.30
Mar2025 ₹406 Cr
206.65
Dec2024 ₹132 Cr
-80.43
Sep2024 ₹677 Cr
1.20
Jun2024 ₹669 Cr
73.05
Mar2024 ₹386 Cr
81.62
Dec2023 ₹213 Cr
-42.36
Sep2023 ₹369 Cr -
PAT Margins
Q-o-Q

8.69 %

Y-o-Y

-26.34 %

Quarters PAT Margin(%) % Change
Jun2025 36.14 %
8.69
Mar2025 33.25 %
19.22
Dec2024 27.89 %
-43.47
Sep2024 49.34 %
0.57
Jun2024 49.06 %
35.67
Mar2024 36.16 %
28.96
Dec2023 28.04 %
-21.63
Sep2023 35.78 % -

NATCO PHARMA Quarterly Earnings Per Share (EPS)

EPS
Q-o-Q

18.18 %

Y-o-Y

-28.11 %

Quarters EPS % Change
Jun2025 ₹26.85
18.18
Mar2025 ₹22.72
205.79
Dec2024 ₹7.43
-80.36
Sep2024 ₹37.84
1.31
Jun2024 ₹37.35
73.08
Mar2024 ₹21.58
81.65
Dec2023 ₹11.88
-42.36
Sep2023 ₹20.61 -

You may also like the below Video Courses